All pregnant women deserve the right to reliable prenatal testing. But until now, screening for trisomies has been limited by the complexity, cost and capacity of existing NIPT technologies. With our high-throughput Vanadis NIPT solution, we’re taking much of the complexity out of cell-free DNA (cfDNA) testing, making it accessible to more women – and more cost-effective for your laboratory.
WE'RE HIRING.If you are as excited as we are to apply cutting-edge research to solving real-world problems and truly making a difference with your work, then contact us to check our current openings.
Breakthrough technology with no sequencing, no PCR
Current sequencing methods, designed to sequence the whole genome, are simply over-dimensionalized for the task of prenatal screening. Even in targeted sequencing, unnecessarily large volumes of genetic data that are irrelevant for aneuoploidy screening must be sequenced and counted. Vanadis NIPT converts only the targeted chromosome regions to fluorescent DNA objects, which are then directly quantified on a microtiter plate scanner.
Vanadis NIPT System Biochemistry Overview
What Makes the Vanadis NIPT System Unique?
eliminating PCR and
sequencing to provide cfDNA
testing to any laboratory
A scalable platform, allowing
a single technician to run up to
20,000 samples per year to cope
with an ever-increasing workload
Leading prenatal screening
software for risk calculation,
supporting the implementation
of all screening models
enabling a streamlined workflow
for greater efficiency
with full traceability of both
samples and reagents
Service and support
from PerkinElmer, the world’s
Our office is located 10 minutes
away from Stockholm city centre
and 20 minutes from
We may recruit students for specific projects. Please visit our careers
website to check whether
opportunities are currently available.